Tallinn-based medtech startup Lifeyear raises €1.3M

Estonian medical technology startup Lifeyear has raised €1.3M from venture funds Verge HealthTech Fund, Tilia Impact Ventures, PurposeTech and Estonian business angels. The company received another €1.5M in technology development grants from the Estonian government. Lifeyear will use the raised funds to launch its digital platform for cardiac care in selected UK hospitals.

Lifeyear is a healthcare technology company that focuses on collecting information about cardiovascular performance. The company was founded in 2021 and is headquartered in Tallinn, Estonia. Lifeyear was founded by a British-Estonian team: British cardiologist Eleanor Weeks, trained by the UK National Health Service, and Estonians Siim Saare (CEO) and Timo Mitt (CTO).

Verge HealthTech Fund is a venture capital fund that invests in early-stage medical technology startups. The company was founded in 2018 in Singapore. The fund's founders are Dr. Joseph Mocanu and Ed Deng.

Tilia Impact Ventures is a venture capital firm specializing in investing in social enterprises. Founded in 2018, it is based in Prague, Czech Republic. The founders are Silke Horáková and Petr Vítek.

PurposeTech is a venture capital company founded in 2022 and headquartered in Prague, Czech Republic. The purpose of the fund is to support technology startups that are focused on creating a positive social impact. The company mainly works in the field of technology startups. The founder of PurposeTech is Zdenek Fred Fous.

More

Latvia's Digmatix acquires Estonian technology company BCS Itera

Baltic Startup Survey 2025